The current financial score of Genelux Corp is 7.03. Its financial status is stable, and its operating efficiency is low.
The current valuation score of Genelux Corp is 6.23. Its current P/E ratio is -2.95, which is -41.79% below the recent high of -1.72 and -1727.88% above the recent low of -53.93.
The current earnings forecast score of Genelux Corp is 8.00. The average price target is 19.00, with a high of 31.00 and a low of 12.00.
The current price momentum score of Genelux Corp is 4.41. Currently, the stock price is trading between the resistance level at 2.87 and the support level at 2.23, making it suitable for range-bound swing trading.
The current institutional shareholding score of Genelux Corp is 3.00. The latest institutional shareholding proportion is 30.96%, representing a quarter-over-quarter increase of 14.81%. The largest institutional shareholder is James Simons, holding a total of 105.23K shares, representing 0.00% of shares outstanding, with 451.90% increase in holdings.
The current risk assessment score of Genelux Corp is 3.10. The company's beta value is 0.54. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.